In May this year, Germany was hit by a Enterohaemorrhagic Escherichia coli (EHEC) epidemic posing a big challenge to the medical community and health policymakers alike. The EHEC bacterium O104:H4 proved to be a tenacious and aggressive pathogen, causing haemolytic uraemic syndrome (HUS) in 860 of 3,000 patients affected.
EHEC/HUS registry, gained a high level of respect and recognition both domestically and internationally. The German Society of Nephrology (DGfN) is holding the EHEC/HUS scientific symposium to share the experience gained from this epidemic.The meeting will take place on September 9, 2011 at the ESTREL Convention in Berlin, Germany.
Internationally renowned experts will discuss the interdisciplinary principles and diagnosis of EHEC infections and the various options for treating EHEC-associated HUS. Initial analyses of the DGfN clinical register will also be presented.
At the time of the outbreak, the EHEC strain and the source of the infection were unknown, and the frequency and severity of the complications that arose took everyone by surprise. No evidence-based data was available on HUS therapy in adult patients, and treatment was ultimately performed as a rescue therapy.
No country is immune to EHEC epidemics. However, compiling more evidence means medical communities can react more effectively and more lives can be saved. Register online for this event or download the flyer with information on the program.
Last modified on Friday, 26 August 2011 11:46